Picture of Aptamer logo

APTA Aptamer News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

REG - AIM - AIM Notice - 09/07/2025

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250709:nRSI2322Qa&default-theme=true

RNS Number : 2322Q  AIM  09 July 2025

NOTICE

 

09/07/2025 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 APTAMER GROUP PLC
 400,419,909  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (BNRRP54)(GB00BNRRP542)

 

 BLUE STAR CAPITAL PLC
 2,471,212  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (BS6Y1X1)(GB00BS6Y1X18)

 

 BLUE STAR CAPITAL PLC
 4,412,096  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (BS6Y1X1)(GB00BS6Y1X18)

 

 EPWIN GROUP PLC
 257,200  ORDINARY SHARES OF 0.05P EACH FULLY PAID  (BNGY4Y8)(GB00BNGY4Y86)

 

 METALS ONE PLC
 1,000,000  ORDINARY SHARES OF GBP0.001 EACH, FULLY PAID  (BSY1D38)(GB00BSY1D385)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUGDRDGGDGUI

Recent news on Aptamer

See all news